Preprint on grey peptide quality

Enyola

Enyola

Explorer
Joined
Nov 29, 2025
Messages
77
Reaction score
82
Location
Austria
Evaluation of Research Grade Peptides Marketed Directly to Consumers Reveals Extensive Variability in Purity and Measured Abundance

I know all about the forum's easter egg concerning where this study got its data. The threads have been read and the videos watched. My thought was to contact the authors, since flawed source data obviously undermines the entire study. Still, making a case built on youtube clips or anecdotal reports won't hold up. According to ChatGPT, no scientific evidence exists.

What would you do?

How is it possible that this lab faces no external quality control?

Is the only reason they escape scrutiny that their customers prefer not to draw legal attention to themselves?
 
The dataset behind the study is fairly solid. Sure, a few problems exist, but by and large the numbers hold together well. As for what the authors conclude, that strikes me as reasonable.

One thing to remember: what we see with Chinese suppliers isn't how the broader public buys. Members here make up just a narrow portion of the overall peptide scene. Odds are plenty more folks are getting taken by scammers over on Tik-Tok compared to those using 'reputable' sellers.

Good Chinese peptides are within reach for us. Yet the majority of buyers out there won't put in the same effort we have to verify that. So for the typical individual, yes, this market is risky, filled with low-grade stuff and outright counterfeits.
 
Enyola said:

Evaluation of Research Grade Peptides Marketed Directly to Consumers Reveals Extensive Variability in Purity and Measured Abundance

I know all about the forum's easter egg concerning where this study got its data. The threads have been read and the videos watched. My thought was to contact the authors, since flawed source data obviously undermines the entire study. Still, making a case built on youtube clips or anecdotal reports won't hold up. According to ChatGPT, no scientific evidence exists.

What would you do?

How is it possible that this lab faces no external quality control?

Is the only reason they escape scrutiny that their customers prefer not to draw legal attention to themselves?
Click to expand...
Enyola - I appreciate you sharing this study. The findings are quite compelling and have heightened my understanding of the potential dangers associated with grey-market peptides—dangers I had some prior knowledge of before deciding to proceed, yet this research offers concrete data on how extensive those dangers are. However, I'm unclear on your interpretation of the study. Could you please explain further? I ask not as a critique but as an admission of my limited experience as someone new to this area.
 
@reta-stacker:

If you go through this thread (the whole thing, not only the opening posts!) and also view this video, then my point will become clear to you.

The dataset behind the study is fairly solid. Sure, a few problems exist, but by and large the numbers hold together well. As for what the authors conclude, that strikes me as reasonable.

One thing to remember: what we see with Chinese suppliers isn't how the broader public buys. Members here make up just a narrow portion of the overall peptide scene. Odds are plenty more folks are getting taken by scammers over on Tik-Tok compared to those using 'reputable' sellers.

Good Chinese peptides are within reach for us. Yet the majority of buyers out there won't put in the same effort we have to verify that. So for the typical individual, yes, this market is risky, filled with low-grade stuff and outright counterfeits.
Click to expand...
To be honest, this was not something I had much awareness of. My only exposure to the subject has come from here and stg.
 
The kinds of discrepancies shown in the videos happen all the time.

With a current HPLC setup that is properly calibrated, the floor for uncertainty is 0.3%, and in practice it is more often 0.5%-1%. So arguing over a difference between 99.4 and 99.5 does not mean anything.

When different labs are involved — particularly when they are not running identical instruments or identical methods (eluent, flow rate, temperature, and so on) — the spread is usually 2%, or can even reach 5%.

In the clip showing the tour of the Janoshik lab, the equipment visible is Shimadzu, and the instrument PM describes as set aside for aGLP-1 peptides is an i-Series (2050 something).

The specs can be found on the manufacturer’s site. They are not especially forthcoming about the uncertainties, though; some digging is required.

If this interests you, I suggest looking at the Agilent site, which is another manufacturer. They have carried out detailed analyses of Tirz, Sema, Lira, and others. It is possible to see that they can detect excipients and residual salts. There are also tests that use different eluents and other changes to the analytical protocol, demonstrating how results shift depending on the protocol, and how degradation products might show up under one set of conditions but not under another.
 
Back
Top